Advanced Biomed Inc. (ADVB) AI Dilution Summary

The company's funding posture rests on its balance sheet: cash was $2,602,697 at 2026-03-31 against estimated monthly burn of $79,925. After that balance-sheet date, the company recorded $600,000 net on 2026-04-13 from an unsecured short-term loan from Jie Wang. The loan bears 10% interest per annum, has a six-month term from disbursement, and is a cash borrowing rather than an equity instrument.